Ethan Caldwell

Ethan Caldwell is a seasoned equity manager with over 15 years of experience on Wall Street, specializing in value and growth investing within the U.S. stock ma

[Ethan Caldwell @hrhrobin]

💥 $SSP +25%!
Bottom breakout confirmed — big volume, strong reversal.
Next stop $3+ 🚀
#SSP #Stocks

[Ethan Caldwell @hrhrobin]

💥 $GCT +30% on massive earnings beat!
Q3 crushed it, Q4 guidance even stronger.
Smart money is loading up — $40 next? 👀
#GCT #Stocks

[Ethan Caldwell @hrhrobin]

🔥 $GMED +36% in one day!
Massive volume. Fresh breakout.
Smart money just arrived — next stop $90+ 🚀
#GMED #NASDAQ #Stocks

[Ethan Caldwell @hrhrobin]

$HAE jumped +32.3% today on heavy volume after a sharp earnings-driven breakout.
The move erased months of losses and reclaimed key technical levels near $65.
If it holds above this range, next resistance sits around $72–$75.
#HAE #NYSE #StockMarket

[Ethan Caldwell @hrhrobin]

$FRGE surged +68% today after Charles Schwab announced a $45 per share cash acquisition.
The stock has now nearly matched the offer price, suggesting limited upside unless a counter-bid emerges.
This was a classic “breakout on buyout” — textbook momentum for short-term traders. 📈
#Mergers #FRGE #NYSE

[Ethan Caldwell @hrhrobin]

$AFJK surged +60.8% today with volume jumping 10x.
The stock broke through key resistance near $12 after months of low activity.
No confirmed catalyst yet — pure momentum play with $18–$20 as new support.
#AFJK #NASDAQ #TechnicalAnalysis

[Ethan Caldwell @hrhrobin]

$KW soared +31% after Q3 results showed a smaller net loss and stronger cash generation from strategic asset sales.

With $9.7B fee-bearing capital and improving balance-sheet efficiency, Kennedy-Wilson is positioning for a recovery in 2026.

#KW #RealEstate #ValueStocks

[Ethan Caldwell @hrhrobin]

$RIGL gained +33% after a powerful earnings-driven breakout.

Revenue jumped 70% YoY, signaling solid traction for TAVALISSE® and Rigel’s expanding hematology pipeline.

If follow-up data confirm this momentum, Rigel could re-enter growth territory. 📈

#RIGL #BiotechStocks #Earnings

[Ethan Caldwell @hrhrobin]

$MTC surged +626% today on massive 337 million volume after receiving Nasdaq compliance attention earlier this quarter.

Despite delisting risk headlines, liquidity returned sharply — short-covering and micro-cap momentum could drive further volatility.

#MTC #MicroCap #NASDAQ

[Ethan Caldwell @hrhrobin]

$PAY surged +26% as Q3 results topped expectations — revenue reached $130.7M (+34% YoY) with EPS of $0.17.

The digital payments firm continues scaling rapidly, benefiting from enterprise adoption and recurring transaction growth. Momentum looks strong heading into Q4.

#PAY #Fintech #Earnings

[Ethan Caldwell @hrhrobin]

$EVOK surged +132% after signing a definitive agreement to be acquired by QOL Medical for $11/share in cash (~139.7% premium).

Combined with its new GIMOTI® patent extending exclusivity through 2036, Evoke Pharma now stands as one of the most attractive niche GI plays in 2025.

#MNA #EVOK #PharmaStocks

[Ethan Caldwell @hrhrobin]

iHeartMedia ($IHRT) surged +37% on reports that Netflix is in talks to license its video podcast content.

The move signals a potential synergy between traditional broadcast and streaming media — if confirmed, it could drive a new revenue stream and boost advertising reach across platforms. 📈

#IHRT #Netflix #MediaStocks

[Ethan Caldwell @hrhrobin]

$ACRV (NASDAQ) rose +17% today with 13M shares traded, marking a clear volume-confirmed breakout above $2.
The stock has been building a multi-month base and may now be entering a new accumulation phase.
Targets: $2.8 → $3.2 if momentum persists. ⚗️📊
#ACRV #NASDAQ #Trading

[Ethan Caldwell @hrhrobin]

$ENVB rebounded +24% today on renewed volume after hitting multi-month lows.
The stock may be forming a short-term bottom near $6.
A sustained close above $7.5 could trigger a retracement toward $9–$10.
One to watch among small-cap biotech recovery names. ⚗️📊
#ENVB #NASDAQ #Trading

[Ethan Caldwell @hrhrobin]

$TERN surged +69.8% today with record-breaking volume.
The stock cleanly cleared its multi-month resistance zone near $11, confirming a technical breakout.
Sustained closes above $15 could trigger a continuation toward $18–$20.
Biotech strength remains notable this week. ⚗️📊
#TERN #Biotech #Trading

[Ethan Caldwell @hrhrobin]

💸 Bank of America calls November a “goldmine month” for investors.
Easing inflation, steady consumer demand, and cooling bond yields could fuel another tech-led run.
📊 Watch sectors: Tech ⚙️, Industrials 🏗️, and Healthcare 🧬.
#USStocks #Investing #BofA #MarketRally

[Ethan Caldwell @hrhrobin]

📈 The S&P 500 just closed out a six-month winning streak — the longest since 2018.
Yet the gains are still concentrated in a few mega-cap tech giants.
Breadth is thin, and the next leg up may depend on small-caps joining the race.
#SP500 #NASDAQ #StockMarket #AIStocks #Finance

[Ethan Caldwell @hrhrobin]

🧬 After rare earths, Beijing’s next leverage might be medicine.
Bloomberg reports China’s booming pharmaceutical exports could become a new chokepoint in US-China competition — shifting the balance of economic power once again.
#USChina #Trade #Pharma #Geopolitics #Bloomberg

[Ethan Caldwell @hrhrobin]

📊 U.S. indices keep breaking records — but the rally is increasingly narrow.
💥 Only a handful of mega-cap tech stocks drive most of the gains while small caps and value names stagnate.
⚠️ A healthy bull needs breadth — watch for rotation into neglected sectors soon.
#StockMarket #NASDAQ #SP500 #Tech #Finance

[Ethan Caldwell @hrhrobin]

🧬 Despite innovation and solid earnings, U.S. healthcare stocks continue to trail the market.
💉 Analysts note valuation discounts up to 30% vs. S&P 500, as AI and tech names dominate flows.
💡 Long-term investors may see this as the most undervalued defensive sector in 2025.
#Healthcare #Stocks #Investing #Value #SP500